Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Order 66 Labs is a biotechnology company focused on revolutionizing drug discovery through the integration of advanced robotics and artificial intelligence. Founded by veterans from Recursion Pharmaceuticals and Starsky Robotics, the company is developing a fully automated laboratory infrastructure designed to accelerate the identification and optimization of novel therapeutic candidates. By leveraging high-throughput screening and machine learning, Order 66 Labs aims to reduce the time and cost associated with traditional drug development. The company's platform emphasizes scalability and data-driven insights to address complex biological challenges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Order 66 Labs.